posted on 2025-08-27, 13:34authored byChristopher D. Parsons, Carl J. Mallia, Matthew
R. Tatton, Calum R. Cook, Cristina García Morales, Andrew D. Campbell, Okky Dwichandra Putra, Steven BullSteven Bull
<p dir="ltr">The development of a manufacturing process for the multikilogram synthesis of 3-bromo-2,5-difluoroaniline required as a starting material for the anticancer KRAS<sup>G12C</sup> inhibitor AZD4625 is described. Two potential synthetic routes to this aniline were identified involving Fe/HCl dissolving metal reduction of the nitro group of 1-bromo-2,5-difluoro-3-nitrobenzene or Pd(0)-catalyzed monoamination of 1,3-dibromo-2,5-difluorobenzene with benzophenone imine to give a haloaryl-imine intermediate that was then hydrolyzed. Optimization of the Pd(0) catalyzed C–N bond-forming step and associated mechanistic studies identified that 0.5 mol % Pd(dba)<sub>2</sub>/Xantphos and four equivalents of K<sub>3</sub>PO<sub>4</sub> in <sup>i</sup>PrOAc at 80 °C could be used to produce 100 kg batches of a haloaryl-imine intermediate. Solutions of this imine in <sup>i</sup>PrOAc were then hydrolyzed through treatment with aqueous HCl allowing the desired aniline <b>1</b> to be isolated as its crystalline HCl salt. Process improvements include reduction of the amount of expensive Pd(dba)<sub>2</sub> precatalyst used from 1.5 to 0.5 mol %, with <sup>i</sup>PrOAc used as a process-friendly solvent that allowed the C–N bond formation and imine hydrolysis steps to be telescoped into a single process. Detailed mechanistic investigations identified that use of excess K<sub>3</sub>PO<sub>4</sub> as a heterogeneous base was necessary to minimize catalyst deactivation and impurity formation in the low-loading Pd(0)-catalyzed C–N bond-forming step.</p>